Cancer stem cells represent an attractive model for in vitro tumor modeling, especially for closer, physiological screening of new anticancer compounds. Although much progress has been made in culturing cancer stem cells, technical challenges persist in the identification and characterization of cell types in a heterogeneous cellular population. In this webinar, our panelist will discuss emerging tools and strategies for the characterization of stem cells derived from heterogeneous populations and applications of this model system for drug discovery. Following the presentation, attendees will have an opportunity to ask questions concerning their specific applications and receive answers in real-time.

Topics to be covered:

  • An overview of 2-D versus 3-D cancer stem cell culture models
  • Screening of anticancer drug treatments using a cancer stem cell-derived model
  • Approaches for characterizing and verifying cell type over time based on intracellular biomarker detection

Meet the Speaker:

Dr. Christian D. Muller
Faculty Member
Faculté de Pharmacie...


Protein Simple

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?